December 2001
1579
C50H60N8O2·(Cl2)·2H2O·CH3OH: N, 11.87; C, 64.89; H, 7.06. Found: N,
Synthesis of a,a-5,15-Bis(2-trans-[PtCl(NH3)2]N-2-aminoethylaminocar
-
11.72; C, 64.92; H, 7.06. FAB-MS m/z: 803 [Calcd for C50H60N8O2 804
bonylphenyl)-2,3,7,8,12,13,17,18-octamethylporphyrin (4b) This por-
phyrin was prepared by a similar procedure to that of the a,b-isomer (4a)
from 3b (50.0 mg, 0.670 mmol) and trans-[PtCl(NH3)2(DMF)]NO3 (pre-
pared in situ from 48.5 mg, 0.160 mmol of trans-[PtCl2(NH3)2] and AgNO3)
in 10 ml of DMF. Yield 21.9 mg (24.3%).
ϩ
H2O
(MϪH) ]. UV–visible spectrum l
nm (log e): 403.0 (5.18), 507.0 (3.95),
max
545.0 (3.69), 565.5, (3.79), 616.5 (3.29).
Synthesis of a,a-5,15-Bis((o-N,N,N-trimetylammoiummethylamido)-
phenyl)-2,3,7,8,12,13,17,18-octamethylporphyrin (7b) This porphyrin
was prepared from 6b (105 mg, 0.136 mmol), by a similar procedure to that
of the corresponding a,b-isomer (7a), yielding 77.4 mg (65.3%).
Rf valueϭ0.50 (n-C4H9OH : (CH3)2CO : H2O : NH4OHϭ5 : 3 : 1 : 1) RP-8.
1H-NMR (DMF-d7) d: Ϫ2.26 (2H, s, pyrrole-NH), 2.53 (12H, s, 2,8,12,18-
CH3), 2.79 (4H, br, –CH2–NH2), 2.95 (4H, br, –CO–NH–CH2–), 3.58 (12H,
s, 3,7,13,17-CH3), 3.88 (12H, br, Pt-NH3), 5.53 (4H, br, –CH2–NH2), 7.97
(2H, t, ph-H), 8.19 (2H, d, ph-H), 8.25 (2H, d, ph-H), 8.51 (2H, br, –CO–
NH–), 10.30 (2H, s, 10,20-H). IR (KBr) cmϪ1: 695 (pyrrole-NH), 2955,
2926, 1161, 1137 (pyrrole–CH3), 1642 (–CONH–), 3400 (–NH2), 327 (Pt-
Cl), 3249 (Pt-NH3). Anal. Calcd for C46H62Cl2N12O2Pt2·(Cl2)·2CHCl3: N,
10.60; C, 36.36; H,4.07. Found: N, 11.25; C, 35.89; H, 4.41. FAB-MS m/z:
1
Rf valueϭ0.37 RP-8 (H2O : CH3COOH : CH3OH : C5H5Nϭ2 : 2 :1 : 1). H-
NMR (CD3OD) d: 2.55 (12H, s, 2, 8, 12, 18-CH3), 2.66 (18H, s, N-(CH3)3),
3.30 (4H, m, –NH–CO–CH2–), 3.54 (12H, s, 3, 7, 13, 17-CH3), 7.70 (2H, t,
ph-H), 7.90—7.95 (4H, m, ph-H), 8.28 (2H, d, ph-H), 10.31 (2H, s, 10,20-
H). IR (KBr) cmϪ1: 693 (pyrrole-NH), 2962, 2926, 1160, 1135 (pyrrole–
CH3), 3238, 1695 (–CONH–), 3410 (NϩϪCH3). Anal. Calcd for
C50H60N8O2·5H2O: N, 11.60; C, 62.16; 7.30. Found: N, 11.59; C, 62.62; H,
6.95. FAB-MS m/z: 803 [Calcd for C50H60N8O2 804 (MϪH)ϩ]. UV–visible
ϩ
H2O
1275 [Calcd for C46H62Cl2N12O2Pt2 1275 M ]. UV–visible spectrum l max
nm (log e); 406.0 (4.91), 514.0 (3.95), 547.5 (3.49), 575.0 (3.63), 622.5
(3.00).
H2O
spectrum l max nm (log e): 400.0 (4.93), 511.5 (3.76), 547.0 (3.47), 573.5
(3.59), 621.0 (3.00)
Synthesis of a,a-5,15-Bis((o-pentaneaminocarbonyl)phenyl)-2,3,7,8,
12,13,17,18-octamethylporphyrin (8) A mixture of 3b (1.00 g, 1.51
mmol) and 6 M HCl (100 ml) was heated at 60 °C with stirring for 8 h. The
solution was cooled, diluted with water (100 ml), and neutralized with 5 M
aqueous ammonia (ca. 90 ml). The precipitate was recoverd by filtration and
the solid was washed with water, and dried in vacuo to afford the hydrolyzed
product. The product was dissolved in dichloromethane (20 ml) and was
cooled to 5 °C. Oxalyl chloride (3.0 ml, 37 mmol) was carefully added below
10 °C and the reaction mixture was stirred for 2 h. The solvent and excess
oxalyl chloride was removed in vacuo. The residue was then redissolved in a
small amount of dichloromethane, and the solvent was again removed in
vacuo. The resultant acid chloride of porphyrin in dichloromethane (30 ml)
was added to dichloromethane solution (20 ml) containing 1,5-diaminopen-
tane (0.20 g, 0.20 mmol) and the mixture was stirred for 12 h at 0 °C. Then
the solution was poured into water and was extracted with dichloromethane
(3ϫ200 ml). The organic layer was washed with water, 2% aqueous sodium
bicarbonate, and water, in turn. The organic layer was dried over anhydrous
sodium sulfate. Evaporation of the solvent gave a purple solid which was
chromatographed on a silica-gel column (3fϫ50 cm) eluted with chloro-
form. The main brown fraction was collected to yield 550 mg of 8 (50.0%).
Strapped Porphyrin 8: 1H-NMR (CDCl3) d: Ϫ4.7—Ϫ4.5 (4H, m,
–CH2–CH2–NHCO–), Ϫ2.28 (2H, s, pyrrole-NH), Ϫ1.40—Ϫ1.34 (4H, m,
–CH2–NHCO–), Ϫ1.53 (2H, m, –CH2–CH2–CH2–NHCO–), 2.52 (12H, s, 2,
8, 12, 18-CH3), 3.55 (12H, s, 3, 7, 13, 17-CH3), 7.86—7.97 (6H, m, ph-H),
8.63—8.65 (2H, m, ph-H), 10.21 (2H, s, 10,20-H). Anal. Calcd for
C47H48N6O2·CHCl3·H2O: N, 9.70; C, 66.85; 5.93. Found: N, 9.39; C, 66.85;
H, 5.80. FAB-MS m/z: 729 [Calcd for C47H48N6O2 729 Mϩ].
Synthesis of a,b-5,15-Bis((o-N,N-dimetylaminomethylamido)phenyl)-
2,3,7,8,12,13,17,18-octamethylporphyrin (6a) N,N-dimethylglycine hy-
drochloride (940 mg, 6.76 mmol) was dissolved in dichloromethane (5 ml)
and cooled to 5 °C. Oxalyl chloride (3.0 ml, 37 mmol) was carefully added to
the solution below 10 °C and the reaction mixture was stirred for 2 h. The
solvent and excess oxalyl chloride were removed in vacuo. The residue of
acid chloride was then redissolved in a small amount of dichloromethane,
and the solvent was again removed in vacuo. The residue was dissolved
in dichloromethane (30 ml) and the solution was added slowly to
dichloromethane (50 ml) containing aminoporphyrin 5a (1.00 g, 1.65 mmol),
and the reaction mixture was stirred at 0 °C. After the addition was complete
(ca. 2 h), triethylamine (4 ml) was added to the solution, and the mixture was
stirred for 8 h at 0 °C. Then the solution was poured into water and was ex-
tracted with dichloromethane (3ϫ200 ml). The organic layer was washed
with water, 2% aqueous sodium bicarbonate, and water, in turn. The organic
layer was dried over anhydrous sodium sulfate. Evaporation of the solvent
gave a purple residue which was chromatographed on a silica-gel column
(3fϫ50 cm) eluted with 10% diethyl ether in chloroform, yielding 6a,
570 mg (44.3%).
a,b-Isomer 6a: Rf valueϭ0.78 (CHCl3 : C6H6 : C2H5OHϭ20 : 20 : 1). 1H-
NMR (CDCl3) d: Ϫ2.51 (2H, s, pyrrole-NH), 1.33 (4H, s, –NH–CO–CH2–),
2.11 (12H, s, N-(CH3)2), 2.35 (12H, s, 2, 8, 12, 18-CH3), 3.34 (12H, s, 3, 7,
13, 17-CH3), 7.33 (2H, t, ph-H), 7.65 (2H, t, ph-H), 7.72 (2H, d, ph-H), 8.61
(2H, d, ph-H), 8.85 (2H, br, –NH–CO–), 10.01 (2H, s, 10,20-H). IR (KBr)
cmϪ1: 693 (pyrrole-NH), 2963, 2926, 1160, 1136 (pyrrole–CH3), 3273, 1688
(–CONH–). Anal. Calcd for C48H54N8O2·1/2(C2H5)2O: N, 13.80; C, 73.95;
H, 7.32. Found: N, 13.84; C, 73.53; H, 7.07. FAB-MS m/z: 775 [Calcd for
C48H54N8O2 775 Mϩ].
Synthesis of a,a-5,15-Bis((o-N,N-dimetylaminomethylamido)phenyl)-
2,3,7,8,12,13,17,18-octamethylporphyrin (6b) This porphyrin was pre-
pared from 5b (1.00 g, 1.65 mmol) by a similar procedure to that of the cor-
responding a,b-isomer (6a), yielding 370 mg (28.8%).
References
1) Lippert B. (ed.), “Cisplatin,” Verlog Helvetica chimica acta, Zurich,
1999, pp. 73—157.
2) Eckstein F., Lilley D. M. J. (ed.), “Nucleic acids And Molecular Biol-
ogy,” Springer, Heidelberg, 1990, pp. 9—38.
Rf valueϭ0.55 (CHCl3 : C6H6 : C2H5OHϭ20 : 20 : 1). 1H-NMR (CDCl3) d:
Ϫ2.25 (2H, s, pyrrole-NH), 1.61 (12H, s, N-(CH3)2), 2.99 (4H, s, –NH–
CO–CH2–), 2.62 (12H, s, 2, 8, 12, 18-CH3), 3.61 (12H, s, 3, 7, 13, 17-CH3),
7.63 (2H, t, ph-H), 7.93 (2H, t, ph-H), 8.06 (2H, d, ph-H), 8.83 (2H, d, ph-
H), 9.10 (2H, br, –NH–CO–), 10.28 (2H, s, 10,20-H). IR (KBr) cmϪ1: 693
(pyrrole-NH), 2962, 2924, 1160, 1136 (pyrrole–CH3), 3217, 1689
(–CONH–). Anal. Calcd for C48H54N8O2·1/2H2O: N, 14.29; C, 73.54; 7.07.
Found: N, 14.07; C, 73.53; H, 7.12.
3) Zlatanova J., Yaneva J., Leuba S. H., FASEB J., 12, 791—799 (1998).
4) a) Zamble D. B., Lippard S. J., Trends Biochem. Sci., 20, 435—439
(1995); b) Zhai X., Beckmann H., Janzen, H.-M., Essigmann J. M.,
Biochemistry, 37, 16307—16315 (1998).
5) a) Fiel R. J., Howard J. C., Mark E. H., Gupta N. G., Nucleic Acid
Res., 6, 3093—3118 (1979); b) Carvlin M. J., Mark E., Fiel R., ibid.,
11, 6121—6139 (1983); c) Marzilli L. G., Pethö G., Lin M., Kim M.
S., Dixon D. W., J. Am. Chem. Soc., 114, 7575—7577 (1992); d)
Mukundan N. E., Pethö G., Dixon D. W., Kim M. S., Marzilli L. G.,
Inorg. Chem., 33, 4676—4687 (1994); e) Ishikawa Y., Yamashita A.,
Uno T., Chem. Pharm. Bull., 49, 287—293 (2001).
6) a) Revew: Marzilli L. G., New J. Chem., 14, 409—420 (1990), and ref-
erences cited therein; b) Pasternack R. F., Gibbs E. J., Villafranca J. J.,
Biochemistry, 22, 2406—2414 (1983); c) Ward B., Skorobogaty A.,
Dabriwiak J. C., ibid., 25, 7827—7833 (1986); d) Sari M. A., Battioni
J. P., Dupré D., Mansuy D., Le Pecq J. B., ibid., 29, 4205—4215
(1990); e) Pasternack R. F., Bustamante C., Collings P. J., Giannetto
A., Gibbs E. J., ibid., 115, 5395—5399 (1993); f ) Pethö G., Elliott N.
B., Kim M. S., Lin M., Dixon D. W., Marzilli L. G., J. Chem. Soc.,
Chem. Commun., 1993, 1547—1548; g) Kuroda R., Tanaka H., ibid.,
1994, 1575—1576; h) McKinnie R. E., Choli J., Bell J. W., Gibbs E. J.,
Pastanack R. F., J. Inorg. Biochem., 32, 207—224 (1988).
Synthesis of a,b-5,15-Bis((o-N,N,N-trimetylammoniummethylamido)-
phenyl)-2,3,7,8,12,13,17,18-octamethylporphyrin (7a) Iodomethan (0.20
ml, 3.2 mmol) was added to a DMF solution (20 ml) containing 6a (105 mg,
0.136 mmole) at room temperature and the solution was stirred for 3 h. Ether
(20 ml) was added to the reactant to produce a solid. After filteration, the re-
sultant solid was dissolved in methanol and chromatographed on a caion-ex-
change resin column (Amberlist A-21: 2fϫ25 cm) to exchange the counter
ion to ClϪ. The column was eluted with methanol. The eluate was evapo-
rated to dryness and was recrystallized from methanol/acetone, yielding
107 mg (90.0%).
Rf valueϭ0.52 RP-8 (H2O : CH3COOH : CH3OH : C5H5Nϭ2 : 2 : 1 : 1). 1H-
NMR (CD3OD) d: 2.24 (18H, s, N-(CH3)3), 2.47 (12H, s, 2, 8, 12, 18-CH3),
3.09 (4H, s, –NH–CO–CH2–), 3.44 (12H, s, 3, 7, 13, 17-CH3), 7.66 (2H, t,
ph-H), 7.82 (2H, t, ph-H), 7.98 (2H, d, ph-H), 8.08 (2H, d, ph-H), 10.24 (2H,
s, 10,20-H). IR (KBr) cmϪ1: 693 (pyrrole-NH), 2963, 2926, 1160, 1136
(pyrrole–CH3) 3276, 1686 (–CONH–), 3413 (NϩϪCH3). Anal. Calcd for
7) a) Dorphin D. (ed.), “The porphyrins,” Vol. I, Chapter 4, Academic